NL301322I2
(nl )
2025-05-27
Repotrectinib en/of farmaceutisch aanvaardbare zouten daarvan
IL258931A
(en )
2018-06-28
Therapeutic compounds and methods
IL259747A
(en )
2018-07-31
Antibodies targeting fc receptor-like 5 and methods of use
EP4212536C0
(en )
2025-02-19
BENZOXAZEPINE OXAZOLIDINONE COMPOUNDS AND METHODS OF USE
IL251970B
(en )
2021-12-01
Anti-cd79b antibodies and methods of use
IL254039A0
(en )
2017-10-31
Anti-pvrig antibodies and methods of use
IL252602B
(en )
2020-10-29
Oral care compositions and methods of use
IL251972B
(en )
2022-03-01
Analyzing and utilizing landscapes
PL3353210T3
(pl )
2025-02-24
Przeciwciała anty-TIGIT i sposoby stosowania
HUE046000T2
(hu )
2020-01-28
Antiproferatív vegyületek és alkalmazásuk módszerei
PL3215532T3
(pl )
2020-03-31
Przeciwciała anty-TIM3 i sposoby ich zastosowania
PT3548033T
(pt )
2024-08-09
Compostos e respectivos métodos de utilização
PL3179991T3
(pl )
2022-02-14
Kombinacje terapeutyczne inhibitora btk i inhibitora bcl-2
IL251988A0
(en )
2017-06-29
Glycan-interacting compounds and methods of use
IL251505A0
(en )
2017-05-29
Neuroactive compounds and methods of use thereof
PL3250610T3
(pl )
2024-01-29
Przeciwciała anty-FcRn i sposoby ich stosowania
DK3160956T3
(da )
2020-08-31
Inhibitorer af lysin-specifik demethylase-1
DK3089971T3
(da )
2020-08-31
Forbindelser og fremgangsmåder til anvendelse
EP3174475C0
(en )
2023-09-06
CATHETER DEVICES AND KITS
DK3511319T3
(da )
2023-07-31
Hæmmere af lysinspecifik demethylase-1
BR112016020889A2
(pt )
2018-08-07
variantes de hppd e métodos de uso
DK3132009T3
(da )
2023-02-06
Fremgangsmåde
IL251167A0
(en )
2017-04-30
Cytotoxic and anti-mitotic compounds, and methods of using the same
IL251836A0
(en )
2017-06-29
Compositions and methods for physiological delivery using cannabidiol
IL313083A
(en )
2024-07-01
Terlipressin compositions and their methods of use